Company: EHSI
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001437749-25-026553
Chunk: 8

Company: Elite Health Systems Inc.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 1
Chunk 8
---
			15,000

			Stock subscription receivable

			175,000

			-

			Accounts payable and accrued expenses

			71,000

			(11,000
			)

			Operating lease right-of-use liability

			(17,000
			)

			(10,000
			)

			Advances to unconsolidated entities

			(4,000
			)

			Net cash provided by (used in) operating activities

			(631,000
			)

			(916,000
			)

			Cash flows from investing activities:

			Receipt of distributions outstanding

			11,000

			-

			Capitalization of software development costs

			(767,000
			)

			Net cash provided by (used in) investing activities

			(756,000
			)

			-

			Cash flows from financing activities:

			Sale of shares

			460,000

			545,000

			Issuance of common stock

			14,000

			2,100,000

			Net cash provided by (used in) financing activities

			474,000

			2,645,000

			Net change in cash and cash equivalents

			(913,000
			)

			1,729,000

			Cash and cash equivalents - beginning of period

			4,034,000

			466,000

			Cash and cash equivalents - end of period

			$
			3,121,000

			$
			2,195,000

The accompanying notes to condensed consolidated financial statements are an integral part hereof

7

Note A - Basis of Preparation

Organization and Business

Elite Health Systems Inc., formerly U.S. NeuroSurgical Holdings, Inc. through its wholly-owned subsidiaries, is developing a business to provide Medicare Advantage plans and related services, concentrating initially in California and Nevada.  As used herein, unless the context indicates otherwise, the term "Company" and "Registrant" means Elite Health Systems Inc. and its wholly-owned subsidiary, Elite Health Systems Holdings Inc. (“EHSH”), and the wholly-owned subsidiaries of EHSH, U.S. NeuroSurgical Physics, Inc., USN Corona, Inc., Elite Health Plan, Inc. and Elite Health Plan of Nevada,